# CONJUGON INC: Form D filings

CONJUGON INC, a biotechnology company in Madison, WI, filed 4 Form D notices with the SEC between 2010 and 2016. The latest, on April 25, 2016, reports $375,000 sold of a $5.8 million offering to 1 investor.

Find out what CONJUGON INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20CONJUGON%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=CONJUGON%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fconjugon-inc-1209987)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20CONJUGON%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=CONJUGON%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fconjugon-inc-1209987)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Wisconsin](https://specstream.ai/data/form-d/state/wisconsin): 361 rows, by operating companies, filed since November 1, 2024, $18.05, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/wisconsin
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 505 SOUTH ROSA ROAD, SUITE 29, Madison, WI, 53719
- Phone: (608) 441-2794
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Wisconsin
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1209987

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 25, 2016 | New notice | $5,750,000 | $375,000 | $5,375,000 | 1 | Apr 8, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1209987/000101532516000049/0001015325-16-000049-index.htm) |
| Feb 9, 2015 | New notice | $1,500,000 | $700,000 | $800,000 | 4 | Aug 5, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1209987/000089271215000197/0000892712-15-000197-index.htm) |
| Dec 4, 2013 | New notice | $1,000,000 | $595,000 | $405,000 | 14 | Nov 26, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1209987/000120998713000001/0001209987-13-000001-index.htm) |
| May 10, 2010 | New notice | $4,750,000 | $1,925,000 | $2,825,000 | 3 | Apr 30, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1209987/000089271210000410/0000892712-10-000410-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Gary Thomas Noskin | Director |  |
| H. Thomas Watkins | Director |  |
| Paul T. Evans | Director |  |
| Steven R. Watt | Executive Officer |  |
| Robert Lippert | Executive Officer, Director |  |
| Carl R. Spalding | Director |  |
| Richard Thomas Burgess | Director |  |

[Every Form D from the week of Apr 25, 2016](https://specstream.ai/data/form-d/week/2016-04-25) · [All recent filings in Wisconsin](https://specstream.ai/data/form-d/state/wisconsin) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what CONJUGON INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).